Venclexta, active pharmaceutical ingredients for Venetoclax, this is a kind of oral B cell lymphoma factor - 2 (BCL - 2) inhibitors, the BCL - 2 in cell apoptosis (programmed cell death) plays an important role, can prevent some of the apoptotic cells, including lymphocytes, and excessive expression in certain types of cancer, is associated with the formation of drug resistance.
Indications: for the patients with tumor
Specification: 250 mg * 56 grains
Retail price: $600
Note: Venclexta active pharmaceutical ingredient for Venetoclax